After your heart transplant, your doctor and treatment team may recommend that you make exercise and physical activity a regular part of your life to continue to improve your overall physical and mental health.
Exercising regularly can help you control your blood pressure, reduce stress, maintain a healthy weight, strengthen your bones and increase your physical function.
Your Mayo Clinic treatment team will create an exercise program designed to meet your individual needs and goals. You'll participate in cardiac rehabilitation to help improve your endurance, strength and energy. Cardiac rehabilitation incorporates education and exercise to help you improve your health and recover after your heart transplant.
Mayo Clinic offers a Cardiac Rehabilitation Program at Mayo Clinic's campuses in Arizona, Florida and Minnesota to help people who have had a heart transplant or who have had heart disease recover and improve their health. A multidisciplinary team of specialists works together as a team to provide care.
Your exercise program may include warm-up exercises such as stretching or slow walking. Your treatment team may suggest physical activities such as walking, bicycling and strength training as part of your exercise program. Specialists in the treatment team will likely recommend you cool down after you exercise, perhaps by walking slowly. Discuss with your treatment team what activities may be appropriate for you.
Take a break from exercising if you feel tired. If you feel symptoms such as shortness of breath, nausea, irregular heart rate or dizziness, stop exercising. If your symptoms don't go away, contact your doctor right away.
Sept. 19, 2017
- What is a heart transplant? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/ht. Accessed April 8, 2016.
- Mancini D. Indications and contraindications for cardiac transplantation. http://www.uptodate.com/home. Accessed April 8, 2016.
- Colvin M, et al. OPTN/SRTR annual data report 2014: Heart. American Journal of Transplantation. 2016;16:115.
- What is a ventricular assist device? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/vad. Accessed April 7, 2016.
- What is a total artificial heart? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/tah. Accessed April 12, 2016.
- Flynn B, et al. Heart and lung transplantation. Current Opinion in Anaesthesiology. 2014;27:153.
- Goldman L, et al., eds. Cardiac transplantation. In: Goldman-Cecil Medicine. 25th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. http://www.clinicalkey.com. Accessed April 7, 2016.
- Pham MX. Prognosis after cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
- Pham MX. Induction and maintenance of immunosuppressive therapy in cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
- Pina IL. Rehabilitation after cardiac transplantation. http://www.uptodate.com/home. Accessed April 12, 2016.
- McKenna WJ. Treatment of amyloid cardiomyopathy. http://www.uptodate.com/home. Accessed April 1, 2016.
- What are the risks of heart surgery? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/hs/risks. Accessed April 12, 2016.
- Barbara Woodward Lips Patient Education Center. Heart transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
- Partnering with your transplant team: The patient's guide to transplantation. U.S. Department of Health and Human Services. https://optn.transplant.hrsa.gov/learn/patient-education/. Accessed April 12, 2016.
- What every patient needs to know. United Network for Organ Sharing. http://www.transplantliving.org/community/patient-resources/publications/. Accessed April 13, 2016.
- Diet and exercise. United Network for Organ Sharing: Transplant living. http://www.transplantliving.org/after-the-transplant/staying-healthy/diet-and-exercise/. Accessed April 13, 2016.
- Eisen HJ. Prevention and treatment of cardiac allograft vasculopathy. http://www.uptodate.com/home. Accessed April 13, 2016.
- Topilsky Y, et al. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation. 2012;125:708.
- Transplant gives recipient chance to re-establish priorities. Mayovox. August 1988;39:1.
- Heart transplant program to resume in fall of 1986. Mayovox. January 1986;37:1.
- Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 8, 2016.
- Matsuo Y, et al. Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation. The Journal of Heart and Lung Transplantation. 2013;32:784.
- Gertz MA, et al. Pathophysiology and treatment of cardiac amyloidosis. Nature Reviews Cardiology. 2015;12:91.
- Williams BA, et al. Heart failure and heart rhythm disorders. In: Current Diagnosis & Treatment: Geriatrics. 2nd ed. New York, N.Y.: The McGraw-Hill Companies; 2014. http://www.accessmedicine.com. Accessed April 21, 2016.
- Guddetti RR, et al. Clinical implications of intracoronary imaging in cardiac allograft vasculopathy. Circulation: Cardiovascular Imaging. 2015;8:e002636.
- Yancy CW, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62: e147.
- Yip DS (expert opinion). Mayo Clinic, Jacksonville, Fla. May 24, 2016.
- Medical practice report: Heart transplant. Press Ganey. http://www.pressganey.com/. Accessed May 24, 2016.
- Lund LH, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second official adult heart transplantation report — 2015; focus theme: Early graft failure. The Journal of Heart and Lung Transplantation. 2015;34:1244.
- Procedure details
- More about